UK Wound Care Management Medical Equipment Industry Report

Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

Product Code GMD04574
Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 216
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

UK Wound Care Management Medical Equipment Industry Report

Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

This report is an essential source for in-depth information and data relating to UK wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in UK

Scope

  • The report provides sector information broken down into detailed categories and segments in country.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Wound Care Management
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
    • 3.3 Healthcare Policy
  • 4 Wound Care Management in United Kingdom
    • 4.1 Wound Care Management Overall Revenues (2000-2012)
    • 4.2 Wound Care Management Overall Volume (2000-2012)
    • 4.3 Wound Care Management Overall Company Shares (2005-2006)
  • 5 Wound Closure Devices in United Kingdom
    • 5.1 Wound Closure Devices Overall Revenues (2000-2012)
      • 5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
      • 5.1.2 Hemostats Overall Revenues (2000-2012)
      • 5.1.3 Tissue Sealants Overall Revenues (2000-2012)
    • 5.2 Wound Closure Devices Overall Volume (2000-2012)
      • 5.2.1 Skin Closure Devices Overall Volume (2000-2012)
      • 5.2.2 Tissue Sealants Overall Volume (2000-2012)
      • 5.2.3 Hemostats Overall Volume (2000-2012)
    • 5.3 Wound Closure Devices Average Price (2000-2012)
      • 5.3.1 Hemostats Average Price (2000-2012)
      • 5.3.2 Tissue Sealants Average Price (2000-2012)
      • 5.3.3 Skin Closure Devices Average Price (2000-2012)
    • 5.4 Wound Closure Devices Distribution Share (2005-2006)
    • 5.5 Wound Closure Devices Company Share (2005-2006)
  • 6 Ostomy in United Kingdom
    • 6.1 Ostomy Overall Revenue (2000-2012)
    • 6.2 Ostomy Overall Volume (2000-2012)
    • 6.3 Ostomy Average Price (2000-2012)
    • 6.4 Ostomy Distribution Share (2005-2006)
    • 6.5 Ostomy Company Share (2005-2006)
  • 7 Advance Wound Management in United Kingdom
    • 7.1 Advanced Wound Management Overall Revenue (2000-2012)
    • 7.2 Advanced Wound Management Overall Volume (2000-2012)
    • 7.3 Advanced Wound Management Average Price (2000-2012)
    • 7.4 Advanced Wound Management Distribution Share (2005-2006)
    • 7.5 Advanced Wound Management Company Share (2005-2006)
  • 8 Traditional Wound Management in United Kingdom
    • 8.1 Traditional Wound Management Overall Revenue (2000-2012)
    • 8.2 Traditional Wound Management Overall Volume (2000-2012)
    • 8.3 Traditional Wound Management Average Price (2000-2012)
    • 8.4 Traditional Wound Management Distribution Share (2005-2006)
    • 8.5 Traditional Wound Management Company Share (2005-2006)
  • 9 Compression Therapy in United Kingdom
    • 9.1 Compression Therapy Overall Revenue (2000-2012)
    • 9.2 Compression Therapy Overall Volume (2000-2012)
    • 9.3 Compression Therapy Average Price (2000-2012)
    • 9.4 Compression Therapy Distribution Share (2000-2012)
    • 9.5 Compression Therapy Company Share (2005-2006)
  • 10 HARTMANN GROUP Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 Incontinence Management
      • 10.2.2 Operating Theater Management
      • 10.2.3 Other GROUP Activities
      • 10.2.4 Wound Management
      • 10.2.5 Products
      • 10.2.6 History
    • 10.3 Value Chain Analysis
      • 10.3.1 Manufacturing
      • 10.3.2 Product Development
      • 10.3.3 Sales and Marketing
    • 10.4 SWOT Analysis
      • 10.4.1 HARTMANN GROUP Strengths
      • 10.4.2 HARTMANN GROUP Weaknesses
      • 10.4.3 HARTMANN GROUP Opportunities
      • 10.4.4 HARTMANN GROUP Threats
    • 10.5 Financial and Operational Review
    • 10.6 Locations And Subsidiaries
    • 10.7 Recent Developments
      • 10.7.1 Mar 17, 2008: Hartmann Declares 2007 Results
      • 10.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia
      • 10.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm
      • 10.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results
  • 11 Coloplast A/S Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Medical Care
      • 11.2.2 Major Products and Services
      • 11.2.3 History
    • 11.3 Value Chain Analysis
      • 11.3.1 Manufacturing
      • 11.3.2 Product Development
      • 11.3.3 Sales and Marketing
    • 11.4 SWOT Analysis
      • 11.4.1 Coloplast A/S Strengths
      • 11.4.2 Coloplast A/S Weaknesses
      • 11.4.3 Coloplast A/S Opportunities
      • 11.4.4 Coloplast A/S Threats
    • 11.5 Financial and Operational Review
      • 11.5.1 Financial Statements
      • 11.5.2 Financial Ratios
      • 11.5.3 Share Holding Structure
    • 11.6 Locations And Subsidiaries
    • 11.7 Financial Deals Landscape
      • 11.7.1 Coloplast Sells Brachytherapy Business To Core Oncology
      • 11.7.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies
      • 11.7.3 Granville Baird Capital Partners Advisors Acquires Coloplast's Business Unit
      • 11.7.4 McKesson Corporation Acquires Sterling Medical Services
      • 11.7.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor
    • 11.8 Recent Developments
      • 11.8.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary
      • 11.8.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results
      • 11.8.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results
      • 11.8.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results
      • 11.8.5 May 15, 2007: Colplast Declares H1 2007 Results
      • 11.8.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results
      • 11.8.7 Dec 13, 2006: Coloplast Appoints New Chairman
      • 11.8.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results
  • 12 ConvaTec Company Profile
    • 12.1 Company Overview
    • 12.2 Business Overview
      • 12.2.1 Major Products and Services
      • 12.2.2 History
    • 12.3 Locations And Subsidiaries
    • 12.4 Recent Developments
      • 12.4.1 Jan 22, 2008: Vivolution Acquires Patent From BMS
      • 12.4.2 Nov 12, 2007: Alltracel Signs Development Agreement With ConvaTec
  • 13 Baxter International, Inc. Company Profile
    • 13.1 Company Overview
    • 13.2 Business Overview
      • 13.2.1 BioScience
      • 13.2.2 Medication Delivery
      • 13.2.3 Renal
      • 13.2.4 Products
      • 13.2.5 History
    • 13.3 Value Chain Analysis
      • 13.3.1 Manufacturing
      • 13.3.2 Product Development
      • 13.3.3 Sales and Marketing
    • 13.4 SWOT Analysis
      • 13.4.1 Baxter International Inc. Strengths
      • 13.4.2 Baxter International Inc. Weaknesses
      • 13.4.3 Baxter International Inc. Opportunities
      • 13.4.4 Baxter International Inc. Threats
    • 13.5 Financial and Operational Review
    • 13.6 Locations And Subsidiaries
    • 13.7 Financial Deals Landscape
      • 13.7.1 Baiyunshan And Baxter Form A Joint Venture In China
      • 13.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration
      • 13.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital
      • 13.7.4 B. Braun Acquires Renal Therapy Business Of Baxter
      • 13.7.5 Innovata signs a license agreement with Baxter International
      • 13.7.6 Kuros Biosurgery Signs An Agreement With Baxter International
      • 13.7.7 Gambro Signs An Agreement With Baxter
      • 13.7.8 Baxter Healthcare And Gambro Enter Into An Agreement
      • 13.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System
      • 13.7.10 Baxter International And Kaketsuken Enter Into Agreement
      • 13.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful
    • 13.8 Recent Developments
      • 13.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007
      • 13.8.2 Dec 18, 2007: Baxter Elects CFO
      • 13.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend
      • 13.8.4 Aug 01, 2007: Baxter Elects New Board Director
      • 13.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend
      • 13.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization
      • 13.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend
      • 13.8.8 Nov 28, 2006: Baxter Announces Annual Dividend
      • 13.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America
    • 13.9 Baxter International Inc. Pipeline Products
      • 13.9.1 Next-Generation Home Hemodialysis Machine
  • 14 Hollister Incorporated Company Profile
    • 14.1 Company Overview
    • 14.2 Business Overview
      • 14.2.1 Major Products and Services
      • 14.2.2 History
    • 14.3 Locations And Subsidiaries
    • 14.4 Financial Deals Landscape
      • 14.4.1 Larsen & Toubro Limited to Buy Power Technology from Mitsubishi Heavy Industries
      • 14.4.2 L&T to acquire stake in City Union Bank
      • 14.4.3 Larsen & Toubro Limited and ATCO enter joint venture
      • 14.4.4 L&T and EADS sign MoU for joint partnership
      • 14.4.5 JP Morgan & Co, India Development Fund acquires 21.6% in L&T Infrastructure Arm
  • 15 Regulation System
    • 15.1 Medical Equipment Approval Process
      • 15.1.1 Classification of Medical Devices
      • 15.1.2 Conformity Assessment Process
    • 15.2 Medical Device approval fee
    • 15.3 Post Market Surveillance (PMS)
  • 16 Pricing and Reimbursement
    • 16.1 Market Pricing
    • 16.2 Government Policies for Reimbursement
  • 17 Distribution Structure
  • 18 APPENDIX
    • 18.1 Global Markets Direct Research Methodology
    • 18.2 Coverage
    • 18.3 Secondary Research
    • 18.4 Primary Research
    • 18.5 Models
    • 18.6 Forecasts
    • 18.7 Expert Panels
    • 18.8 Currency Conversion
    • 18.9 Contact Us
    • 18.10 Disclaimer
  • List of Tables
    • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
    • Table 2: Wound Care Management, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Table 3: Wound Care Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 4: Wound Care Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 5: Wound Care Management, United Kingdom, Category Revenues ($ mn), 2000-2012
    • Table 6: Wound Care Management, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007
    • Table 7: Wound Care Management, United Kingdom, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 8: Wound Care Management, United Kingdom, Category Volume (Units), 2000-2012
    • Table 9: Wound Care Management, United Kingdom, Category Volume (Units), Historic, 2000-2007
    • Table 10: Wound Care Management, United Kingdom, Category Volume (Units), Forecast, 2007-2012
    • Table 11: Wound Care Management in United Kingdom, Overall, Company Share by Revenue ($ mn), 2005-2006
    • Table 12: Wound Closure Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 13: Wound Closure Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 14: Wound Closure Devices, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 15: Wound Closure Devices, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 16: Skin Closure Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 17: Skin Closure Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 18: Hemostats, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 19: Hemostats, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 20: Tissue Sealants, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 21: Tissue Sealants, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 22: Wound Closure Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 23: Wound Closure Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 24: Skin Closure Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 25: Skin Closure Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 26: Tissue Sealants, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 27: Tissue Sealants, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 28: Hemostats, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 29: Hemostats, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 30: Hemostats, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 31: Hemostats, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 32: Tissue Sealants, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 33: Tissue Sealants, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 34: Skin Closure Devices, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 35: Skin Closure Devices, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 36: Wound Closure Devices, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 37: Wound Closure Devices, United Kingdom, Company Share by Revenue ($ mn), 2005-2006
    • Table 38: Ostomy, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 39: Ostomy, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 40: Ostomy, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 41: Ostomy, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 42: Ostomy, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 43: Ostomy, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 44: Ostomy, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 45: Ostomy, United Kingdom, Company Share by Revenue ($ mn), 2005-2006
    • Table 46: Advanced Wound Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 47: Advanced Wound Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 48: Advanced Wound Management, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 49: Advanced Wound Management, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 50: Advanced Wound Management, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 51: Advanced Wound Management, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 52: Advanced Wound Management, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 53: Advanced Wound Management, United Kingdom, Company Share by Revenue ($ mn), 2005-2006
    • Table 54: Traditional Wound Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 55: Traditional Wound Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 56: Traditional Wound Management, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 57: Traditional Wound Management, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 58: Traditional Wound Management, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 59: Traditional Wound Management, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 60: Traditional Wound Management, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 61: Traditional Wound Management, United Kingdom, Company Share by Revenue ($ mn), 2005-2006
    • Table 62: Compression Therapy, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 63: Compression Therapy, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 64: Compression Therapy, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 65: Compression Therapy, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 66: Compression Therapy, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 67: Compression Therapy, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 68: Compression Therapy, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 69: Compression Therapy, United Kingdom, Company Share by Revenue ($ mn), 2005-2006
    • Table 70: HARTMANN GROUP, SWOT Analysis, 2006
    • Table 71: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006
    • Table 72: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006(Contd.)
    • Table 73: HARTMANN GROUP, Subsidiaries
    • Table 74: Coloplast A/S, SWOT Analysis, 2007
    • Table 75: Coloplast A/S, Financial Statements, DKK Million, 2003-2007
    • Table 76: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007
    • Table 77: Coloplast A/S, Share Holding Structure
    • Table 78: Coloplast A/S, Other Locations
    • Table 79: Coloplast A/S, Subsidiaries
    • Table 80: Coloplast A/S, Subsidiaries(Contd.)
    • Table 81: ConvaTec, Other Locations
    • Table 82: Baxter International Inc., SWOT Analysis, 2006
    • Table 83: Baxter International Inc., Financial Statements, USD Million, 2002-2006
    • Table 84: Baxter International Inc., Financial Ratios, USD Million, 2002-2006 (Contd.)
    • Table 85: Baxter International Inc., Other Locations
    • Table 86: Baxter International Inc., Subsidiaries
    • Table 87: Hollister Incorporated, Other Locations
    • Table 88: Hollister Incorporated, Other Locations (Contd.)
    • Table 89: Hollister Incorporated, Subsidiaries
    • Table 90: Medical Device Approval Fee in UK, 2006
    • Table 91: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • List of Figures
    • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
    • Figure 2: Wound Care Management, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Figure 3 Wound Care Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 4: Wound Care Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 5: Wound Care Management, United Kingdom, Category Revenues ($ mn), 2000-2012
    • Figure 6: Wound Care Management, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 7: Wound Care Management, United Kingdom, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 8: Wound Care Management, United Kingdom, Category Volume (Units), 2000-2012
    • Figure 9: Wound Care Management, United Kingdom, Category Volume (Units), Historic, 2000-2007
    • Figure 10: Wound Care Management, United Kingdom, Category Volume (Units), Forecast, 2007-2012
    • Figure 11: Wound Care Management in United Kingdom, Overall, Company Share (%), 2006
    • Figure 12: Wound Closure Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 13: Wound Closure Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 14: Wound Closure Devices, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 15: Wound Closure Devices, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 16: Skin Closure Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 17: Skin Closure Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 18: Hemostats, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 19: Hemostats, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 20: Tissue Sealants, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 21: Tissue Sealants, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 22: Wound Closure Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 23: Wound Closure Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 24: Skin Closure Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 25: Skin Closure Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 26: Tissue Sealants, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 27: Tissue Sealants, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 28: Hemostats, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 29: Hemostats, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 30: Hemostats, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 31: Hemostats, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 32: Tissue Sealants, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 33: Tissue Sealants, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 34: Skin Closure Devices, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 35: Skin Closure Devices, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 36: Wound Closure Devices, United Kingdom, Distribution Share (%), 2006
    • Figure 37: Wound Closure Devices, United Kingdom, Company Share (%), 2006
    • Figure 38: Ostomy, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 39: Ostomy, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 40: Ostomy, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 41: Ostomy, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 42: Ostomy, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 43: Ostomy, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 44: Ostomy, United Kingdom, Company Share (%), 2006
    • Figure 45: Advanced Wound Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 46: Advanced Wound Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 47: Advanced Wound Management, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 48: Advanced Wound Management, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 49: Advanced Wound Management, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 50: Advanced Wound Management, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 51: Advanced Wound Management, United Kingdom, Distribution Share (%), 2006
    • Figure 52: Advanced Wound Management, United Kingdom, Company Share (%), 2006
    • Figure 53: Traditional Wound Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 54: Traditional Wound Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 55: Traditional Wound Management, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 56: Traditional Wound Management, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 57: Traditional Wound Management, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 58: Traditional Wound Management, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 59: Traditional Wound Management, United Kingdom, Distribution Share (%), 2006
    • Figure 60: Traditional Wound Management, United Kingdom, Company Share (%), 2006
    • Figure 61: Compression Therapy, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 62: Compression Therapy, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 63: Compression Therapy, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 64: Compression Therapy, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 65: Compression Therapy, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 66: Compression Therapy, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 67: Compression Therapy, United Kingdom, Distribution Share (%), 2006
    • Figure 68: Compression Therapy, United Kingdom, Company Share (%), 2006
    • Figure 69: HARTMANN GROUP, Value Chain Analysis
    • Figure 70: Coloplast A/S, Value Chain Analysis
    • Figure 71: Baxter International Inc., Value Chain Analysis
    • Figure 72: Flowchart for Classification of Non-invasive Devices in UK, 2007
    • Figure 73: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 74: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 75: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 76: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 77: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 78: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 79: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
    • Figure 80: Conformity Assessment of Class-I Medical Devices in UK, 2007
    • Figure 81: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
    • Figure 82: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
    • Figure 83: Conformity Assessment of Class-III Medical Devices in UK, 2007
    • Figure 84: Global Markets Direct Methodology